A LEADING medical expert has claimed the privatisation of drug company CSL contributed to the rationing of benzylpenicillin, an important antibiotic for public health.

Professor Peter Collignon, an infectious diseases specialist at the Australian National University in Canberra, told Crikey the supply of important antibiotics should not be entrusted to a single for-profit company.